137
Views
8
CrossRef citations to date
0
Altmetric
Review

Current treatment for primary ciliary dyskinesia conditions

&
Pages 369-377 | Published online: 02 Mar 2005

Bibliography

  • MEEKS M, BUSH A: Primary ciliary dyskinesia (PCD). Pediati: Pulmonol (2000) 29:307–316.
  • AFZELIUS BA, ELIASSON R,JOHNSEN 0, LINDHOLMER C: Lack of dynein arms in immobile human spermatozoa. J. Cell Biol. (1975) 66:225–232.
  • ELIASSON R, MOSSBERG B, CAMNER P, AFZELIUS BA: The immotile cilia syndrome. N Engl. I Med. (1977) 297:1–6.
  • GREENSTONE M, RUTMAN A, DEWAR A, MACKAY I, COLE PJ: Primary ciliary dyskinesia: cytological and clinical features. Quart." Med. (1988) 67:405–430.
  • JONES JG: Clearance of inhaled particles from the alveoli. In: Aerosols, and the Lung. Clinical and Experimental aspects.Clarke SW, Pavia D (Eds.), Butterworth, London, UK (1984): 170–196.
  • LEIGH MW: Primary ciliary dyskinesia. In: Disorders of the Respiratory Tract M Children.Chernick V, Boat TF (Eds.), WB Saunders, Philadelphia, USA (1998):819–825.
  • PERRAUDEAU M: Late presentation of Kartagener's syndrome. Br. Med. (1994) 308:519–521.
  • SCHIDLOW DV: Primary ciliary dyskinesia (the immotile cilia syndrome). Ann. Allergy(1994) 73:457–469.
  • RUTLAND J, DEIONGH R: Random ciliary orientation. A cause of respiratory tract disease. N Engl. J. Med. (1990) 323:1681–1684.
  • •A detailed overview of ultrastructure of cilium.
  • NASTASI KJ, BLAISS MS: A seven-year-old boy with sinusitis, otitis media, and asthma. Ann. Allergy (1994) 73:15–20.
  • RUTLAND J, DEIONGH R: Ciliary dysfunction. In: Pediatric Respir: Med. Taussig LM, Landau LI (Eds.),Mosby, St. Louis, Missouri, USA(1999):1171–1178.
  • DEIONGH RU, RUTLAND J: Ciliary defects in healthy subjects, bronchiectasis and primary ciliary dyskinesia. Am." Respic Crit. Care Med. (1995) 151:1559–1567.
  • STURGESS JM, CHAO J, WONG J, ASPIN N, TURNER JAP: Cilia with defective radial spokes. A cause of human respiratory disease. N Engl. J. Med. (1979) 300:53–57.
  • GREENSTONE MA, DEWAR A,COLE PJ: Ciliary dyskinesia with normal ultrastructure. Thorax (1983) 38:875–876.
  • RAUTIAINEN M, NUUTINEN J, COLLAN Y: Short nasal cilia and impaired mucociliary function. Eur. Arch. Otorhinolaryngol (1991) 248:271–274.
  • AFZELIUS BA: Immotile cilia syndrome: past, present and prospects for the future. Thorax (1998) 53:894–897.
  • COWAN MJ, GLADWIN MT, SHELHAMER JH: Disorders of ciliary motility. Am. J. Med. Sci. (2001) 321:3–10.
  • BUSH A, COLE P, HARIRI M et al: Primary ciliary dyskinesia: diagnosis and standards of care. Eur. Respir: (1998) 12:982–988.
  • ••A thorough review on diagnosis andcomprehensive review of the treatment of PCD.
  • MUNRO NC, CURRIE DC,LINDSAY KS et al.: Fertility in men withprimary ciliary dyskinesia presenting with respiratory infection. Thorax (1994) 49:684–687.
  • BIANCHI E, SAVASTA S, CALIGARO A et al.: HLA haplotype segregation and ultrastructural study in familial immotile cilia syndrome. Hum. Genet. (1992) 89:270–274.
  • PAN Y, MCCASKILL CD,THOMPSON K et al.: Paternal isodisomy of chromosome 7 associated with complete situs inversus and immotile cilia.Am. J. Hum genet. (1998) 62:1551–1555.
  • WITT M, WANG YE WANG S et al: Exclusion of chromosome 7 for Kartagener syndrome but suggestion of linkage in families with other forms of primary ciliary dyskinesia. Am. Hum. Genet. (1998) 64:313–318.
  • COREN ME, MEEKS M, MORRISON I, BUCHDAHL RM, BUSH A: Primary ciliary dyskinesia: age at diagnosis and symptom history. Acta Paediatr. (2002) 91:667–669.
  • ••A good paper to emphasise the importanceof early diagnosis of PCD.
  • EL-SAYED Y, AL-SARHANI A, AL-ESSA A-R: Otological manifestations of primary ciliary dyskinesia.Clin. Otolaryngol (1997) 22:266–270.
  • NOONE PG, BENNETT WD,REGNIS JA et al.: Effect of aerosolised uridine-5'-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia. Am. I Respir. Grit. Care Med. (1999) 160:144–149.
  • •This paper clarify the usefulness of UTP in patients with PCD.
  • BROMIKER R, NEEMAN Z, BAR-OZ B, AVITAL A, BAR-ZIV J, SPRINGER C: Early diagnosis of primary ciliary dyskinesia in a newborn without situs inversus. Acta Paediam. (2002) 91:1002–1011.
  • ROSSMAN CM, FORREST JB,RUFFIN RE, NEWHOUSE MT: Immotile cilia syndrome in persons with and without Kartagener's syndrome. Am. Rev Respir. Dis. (1980) 121:1011–1016.
  • ROSSMAN CM, WALDES R,SAMPSON D, NEWHOUSE MT: Effect of chest physiotherapy on the removal of mucus in patients with cystic fibrosis. Am Rev Respir Dis. (1982) 126:131–135.
  • PHILLIPS GE, THOMAS S, HEATHER S, BUSH A: Airway responsiveness in primary ciliary dyskinesia: intrasubject variability and the effects of exercise and bronchodilatoratherapy. Eur. Respic (1996) 9\(Suppl. 23):365 (Abstract).
  • HASSAN JA, SAADIAH S, ROSLAN H, ZAINUDIN B: Bronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasis. Respirology (1999) 4:423–426.
  • ERNSTSON S, AFZELIUS BA, MOSSBERG B: Otologic manifestations of the immotile-cilia syndrome. Acta Otolaryngol (1984) 97:83–92.
  • JAHRSDOERFER R, FELDMAN PS, RUBEL EW, GUERRANT JL, EGGLESTON PA, SELDEN RF: Otitis media and the immotile cilia syndrome. Laryngoscope (1979) 89:769–778.
  • PARSONS DS, GREENE BA: A treatment for primary ciliary dyskinesia: efficacy of functional endoscopic sinus surgery. Laryngoscope (1993) 103:1269–1272.
  • CHEE L, GRAHAM SM,CAROTHERS DG, BALLAS ZK: Immune dysfunction in refractory sinusitis in a tertiary care setting.Laryngoscope (2001) 111:233–235.
  • SENIOR BA, KENNEDY DW, TANABODEE J, KROGER H, HASSAB M, LANZA D: Long-term results of functional endoscopic sinus surgery. Laryngoscope (1998) 108:151–157.
  • LUND VJ, NEIJENS HJ, CLEMENT PAR, LUSK R, STAMMBERGER H: The treatment of chronic sinusitis: a controversial issue. Int. I Pediatc Otorhinolatyngol (1995) 32:S21–35.
  • DRAKE-LEE AB: Medical treatment of nasal polyps. Rhinology (1994) 32:1–4.
  • SCHWARZENBERG H, ELFELDT RJ, SCHLUTER E, LINK J, HELLER M: Severe haemoptysis requiring lobectomy in an 11-year-old patient with Kartagener's syndrome. Ann. Thorac. Surg. (1997) 64:852–854.
  • HOUTMEYERS E, GOSSELINK R, GAYAN-RAMIREZ G, DECRAMER M: Regulation of mucociliary clearance in health and disease. Ear. Respir. J. (1999) 13:1177–1188.
  • ••A detailed review of mucous rheology andmucociliary clearance of airway.
  • SMIT HJM, SCHREURS JM, VAN DEN BOSCH JMM, WESTERMANN CJJ: Is resection of bronchiectasis beneficial in patients with primary ciliary dyskinesia? Chest (1996) 109:1541–1544.
  • PEDERSEN M, STAFANGER G: Bronchopulmonary symptoms in primary ciliary dyskinesia. A clinical study of27 patients. Eur.j Respir. Dis. (1983) 64:118-128. 42.PHIPPS RJ, NADEL JA, DAVIS B: Effect of alpha-adrenergic stimulation on mucus secretion and on ion transport in cat trachea in vitro. Am. Rev Respir. Dis. (1980) 121:359–365.
  • PHIPPS RJ, WILLIAMS IP,RICHARDSON PS, PELL J, PACK RJ, WRIGHT N: Sympathomimetic drugs stimulate the output of secretory glycoproteins from human bronchi in vitro. Clin. Sci. (Lonch (1982) 63:23–28.
  • BENNETT WD: Effect of P-adrenergic agonists on mucociliary clearance. I Allergy Clin. Immunol (2002) 110:S291–S297.
  • ••An excellent paper showing the benefits ofP-adrenergic agonists on mucociliary clearance.
  • DEVALIA JL, SAPSFORD RJ,RUSZNAK C, TOUMBIS MJ,DAVIES RJ: The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells, in vitro. Palm. Pharmacol (1992) 5:257–263.
  • KOH YY, PARK Y, JEONG JH, KIM CK, MIN YG, CHI JG: The effect of regular salbutamol on lung function and bronchial responsiveness in patients with primary ciliary dyskinesia. Chest (2000) 117:427–433.
  • ••An interesting evaluation of the long-termeffect of regular salbutamol in patients with PCD.
  • FISCHER A, HOFFMANN B: Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Arn. Respic Crit. Care Med. (1996) 154:209–216.
  • BARNES PJ, BELVISI MG: Nitric oxide and lung disease. Thorax (1993) 48:1034–1043.
  • GRASEMANN H, GARTIG SS, WIESSEMANN HG, TESCHLER H, KONIETZKO N, RATJEN F: Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Ear. Respic (1999) 13:114–118.
  • •Results from this study illustrate the effect of L-arginine in patients with PCD.
  • LOUKIDES S, KHARITONOV S, WODEHOUSE T, COLE PJ, BARNES PJ: Effect of arginine on mucociliary function in primary ciliary dyskinesia. Lancet (1998) 352:371–372.
  • SCHUIL PJ, BERGE MT,VAN GELDER GM, GRAAMANS K,HUIZING EH: Effects of prostaglandinD2 and E2 on ciliary beat frequency of human upper respiratory cilia in vitro. Acta Otolaryngol Stockb. (1995) 115:438–442.
  • KNOWLES MR, CLARKE LL,BOUCHER RC: Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N. Engl. Med. (1991) 325:533–538.
  • SURI R, GRIEVE R, NORMAND C et al: Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax (2002) 57:841–846.
  • •A recent study on the effectiveness of hypertonic saline and rhDNase in patients with CE
  • ROBINSON M, REGNIS JA, BAILEY DL,KING M, BAUTOVICH GJ, BYE PTP: Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am. I Respir. Crit. Care Med. (1996) 153:1503–1509.
  • BOEK WM, KELES N, GRAAMANS K, HUIZING EH: Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope (1999) 109:396–399.
  • DESAI M, WELLER PH, SPENCER DA: Clinical benefit from nebulised human recombinant DNase in Kartagener's syndrome. Pediatr. Pulmonol (1995) 20:307–308.
  • •This paper demonstrates the usefulness of rhDNase in patients with PCD.
  • FAHY JV, STEIGER DJ, LIU J, BASBAUM CB, FINKBEINER WE, BOUSHEY HA: Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects. Am. Rev Respir. Dis. (1993) 147:1132–1137.
  • POTTER JL, SPECTOR S,MATTHEWS LW, LEMM J: Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis,and laryngectomy. Am. Rev Respir: Dis.(1969) 99:909–916.
  • FUCHS HJ, BOROWITZ DS, CHRISTIANSEN DH et al.: Effect of aerosolised recombinant human DNase on exacerbation's of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N. Engl.' Med. (1994) 331:317–319.
  • BERGE MT, BRINKHORST G, KROON AA, JONGSTE JC: DNase treatment in primary ciliary dyskinesia-assessment by nocturnal pulse oximetry. Pediatr. Pulmonol (1999) 27:59–61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.